EA
EW icon

Ellsworth Advisors’s Edwards Lifesciences EW Stock Holding History

Ellsworth Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,138
Closed -$4.42M – 146
2021
Q4 		$4.42M Buy
34,138
+1,616
+5% +$188K 1.64% 11
2021
Q3 		$3.68M Buy
32,522
+5,065
+18% +$578K 1.68% 12
2021
Q2 		$2.84M Buy
27,457
+3,065
+13% +$289K 1.39% 23
2021
Q1 		$2.04M Buy
24,392
+2,054
+9% +$174K 1.23% 27
2020
Q4 		$2.04M Buy
22,338
+2,667
+14% +$221K 1.48% 16
2020
Q3 		$1.57M Sell
19,671
-37
-0.2% -$2.89K 1.57% 18
2020
Q2 		$1.36M Buy
+19,708
New +$1.4M 1.49% 22

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ellsworth Advisors's EW Position: Q1 2022 in Review

Ellsworth Advisors sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 34,138 shares — an estimated $4.42M sold.

Ellsworth Advisors first reported a position in EW in Q2 2020 and held it in 7 quarters. The position peaked at $4.42M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Ellsworth Advisors reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Ellsworth Advisors sold 34,138 Edwards Lifesciences shares in Q1 2022, an estimated $4.42M.
  • Ellsworth Advisors first reported a position in Edwards Lifesciences in Q2 2020 and held it in 7 quarters.
  • Ellsworth Advisors's Edwards Lifesciences position peaked at $4.42M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Ellsworth Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.